TScan Therapeutics, Inc.
TCRX
$0.95
-$0.07-6.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 184.45M | 218.05M | 251.69M | 290.11M | 271.12M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.71M | 3.09M | 3.15M | 2.61M | 2.97M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 188.17M | 221.13M | 254.84M | 292.72M | 274.09M |
|
|
|||||
| Total Current Assets | 188.17M | 221.13M | 254.84M | 292.72M | 274.09M |
| Net Property, Plant & Equipment | 68.74M | 70.62M | 71.09M | 71.60M | 67.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.32M | 6.81M | 6.79M | 6.80M | 6.84M |
| Total Assets | 262.23M | 298.56M | 332.71M | 371.12M | 348.03M |
|
|
|||||
| Total Accounts Payable | 6.35M | 4.54M | 4.97M | 4.28M | 3.65M |
| Total Accrued Expenses | 10.58M | 12.61M | 9.41M | 15.33M | 10.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.90M | 6.29M | 4.97M | 4.57M | 3.90M |
| Total Finance Division Other Current Liabilities | 5.38M | 7.89M | 10.47M | 11.77M | 10.18M |
| Total Other Current Liabilities | 5.38M | 7.89M | 10.47M | 11.77M | 10.18M |
| Total Current Liabilities | 29.21M | 31.32M | 29.82M | 35.96M | 28.66M |
|
|
|||||
| Total Current Liabilities | 29.21M | 31.32M | 29.82M | 35.96M | 28.66M |
| Long-Term Debt | 32.41M | 32.30M | 32.18M | 32.07M | 30.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.30M | 58.12M | 59.88M | 60.74M | 55.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 278.00K | 113.00K | 625.00K | 1.38M | 3.82M |
| Total Liabilities | 118.20M | 121.85M | 122.51M | 130.15M | 118.94M |
|
|
|||||
| Common Stock & APIC | 625.90M | 622.89M | 619.43M | 616.02M | 568.37M |
| Retained Earnings | -481.89M | -446.18M | -409.22M | -375.10M | -339.29M |
| Treasury Stock & Other | 2.00K | -4.00K | -4.00K | 51.00K | -- |
| Total Common Equity | 144.02M | 176.71M | 210.20M | 240.97M | 229.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 144.02M | 176.71M | 210.20M | 240.97M | 229.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 144.02M | 176.71M | 210.20M | 240.97M | 229.09M |
|
|
|||||